Global Medical REIT Inc. (NYSE:GMRE) Shares Sold by B. Riley Wealth Advisors Inc.

B. Riley Wealth Advisors Inc. trimmed its holdings in Global Medical REIT Inc. (NYSE:GMREFree Report) by 20.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 19,357 shares of the company’s stock after selling 4,948 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in Global Medical REIT were worth $193,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in GMRE. Gordian Capital Singapore Pte Ltd acquired a new stake in shares of Global Medical REIT in the second quarter worth approximately $100,000. Quantinno Capital Management LP purchased a new position in Global Medical REIT during the third quarter worth approximately $138,000. Zacks Investment Management boosted its holdings in shares of Global Medical REIT by 12.9% in the 3rd quarter. Zacks Investment Management now owns 14,803 shares of the company’s stock valued at $147,000 after purchasing an additional 1,696 shares during the last quarter. Intech Investment Management LLC purchased a new stake in shares of Global Medical REIT during the 3rd quarter valued at $150,000. Finally, Versor Investments LP acquired a new stake in shares of Global Medical REIT during the 3rd quarter worth $189,000. Hedge funds and other institutional investors own 57.52% of the company’s stock.

Global Medical REIT Trading Down 1.1 %

Shares of GMRE opened at $7.86 on Monday. Global Medical REIT Inc. has a 12 month low of $7.68 and a 12 month high of $11.59. The stock’s 50-day moving average is $8.88 and its two-hundred day moving average is $9.18. The company has a debt-to-equity ratio of 1.26, a current ratio of 0.28 and a quick ratio of 0.28. The stock has a market cap of $525.07 million, a PE ratio of -392.80, a P/E/G ratio of 1.47 and a beta of 1.21.

Global Medical REIT (NYSE:GMREGet Free Report) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.21 by ($0.18). Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. The company had revenue of $34.26 million for the quarter, compared to analyst estimates of $34.88 million. During the same period last year, the firm posted $0.23 earnings per share. Equities analysts forecast that Global Medical REIT Inc. will post 0.83 earnings per share for the current fiscal year.

Global Medical REIT Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 8th. Investors of record on Friday, December 20th will be issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 10.69%. The ex-dividend date is Friday, December 20th. Global Medical REIT’s payout ratio is -4,200.00%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Berenberg Bank began coverage on Global Medical REIT in a report on Friday, October 18th. They issued a “buy” rating and a $11.75 price objective on the stock. Alliance Global Partners initiated coverage on shares of Global Medical REIT in a report on Thursday, September 19th. They issued a “buy” rating and a $12.00 price target on the stock.

Get Our Latest Research Report on GMRE

Global Medical REIT Profile

(Free Report)

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Featured Articles

Institutional Ownership by Quarter for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.